Budesonide 0.5 mg + Levosalbutamol 0.63 mg is a combination respiratory formulation used for the management of asthma, chronic obstructive pulmonary disease (COPD), bronchospasm, and other obstructive airway conditions. Budesonide is a corticosteroid that reduces inflammation, swelling, and mucus production in the airways. Levosalbutamol is a selective beta2-agonist bronchodilator that relaxes airway muscles, providing quick relief from wheezing and shortness of breath. This combination provides both anti-inflammatory control and rapid bronchodilation, making it highly effective in both acute exacerbations and maintenance therapy when prescribed. It is commonly administered via respiratory inhalation solution or nebulizer, ensuring direct delivery to the lungs for faster and targeted action.
